Humana Inc. (NYSE: HUM) announced today that Regina Nethery, Vice
President of Investor Relations, will make a presentation to investors
at the Oppenheimer 24th Annual Healthcare Conference on
Wednesday, December 11, 2013, at...
MedAssets (NASDAQ: MDAS) today announced that it will participate in the
Oppenheimer & Co. Inc. 24th Annual Healthcare Conference
on Tuesday, December 10, 2013 in New York City. The company’s formal
presentation is scheduled...
Community Health Systems, Inc. (NYSE: CYH) today announced that
management will participate in the Oppenheimer 24th Annual
Healthcare Conference to be held December 10-11, 2013, at the Crowne
Plaza Times Square in New York...
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical
company that develops, manufactures, and intends to market specialty
plasma-based biologics for the treatment and prevention of certain
The share prices of Galena Biopharma Inc. (GALE) have enjoyed a rally of approximately 58.4% since November 11, with bumps and falls during this time. The shares initially soared on the
Phase I trial results of folate binding...
Newfoundland, NJ, November 27, 2013 --(PR.com)-- Encore.org has announced that Gary Oppenheimer of Newfoundland NJ is a 2013 Purpose Prize fellow. The Purpose Prize is the nation’s only large-scale investment in social entrepreneurs and other...
MAXIMUS (NYSE: MMS), a leading provider of government services
worldwide, announced today that Richard Montoni, President and Chief
Executive Officer, and Lisa Miles, Senior Vice President of Investor
Relations, will present...
Incyte Corporation (Nasdaq:INCY) announced today it will present at the
Oppenheimer 24th Annual Healthcare Conference on Wednesday,
December 11 at 10:40 a.m. (EST) in New York.
The presentation will be webcast live and can...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Oppenheimer Holdings (OPY):